This concentration injected is lower than has been used for efficacy studies of other monoclonal antibodies against MMP-14 [33–35] and yet there was a highly significant impact on both primary tumor growth and, more importantly, on metastatic spread. This evidence concerns the gene MMP14 and neoplasm.